Exenatide (Byetta, Bydureon) Explained: The First GLP-1 and Why It Came From a Lizard

If you have heard that Ozempic owes its existence to a lizard, the honest answer is yes — but the full story runs through a Bronx veterans' hospital, three decades of skepticism, and a regulatory landscape that looked very different before anyone had heard of semaglutide. Exenatide was the first GLP-1 receptor agonist to reach

Exenatide (Byetta, Bydureon) Explained: The First GLP-1 and Why It Came From a Lizard Read More »

Dulaglutide (Trulicity) Explained: A Weekly GLP-1 With a Cardiovascular Outcomes Story

If you are reading about Trulicity because someone in your life takes it for weight loss, the first thing worth knowing is that dulaglutide does not have an FDA-approved weight-management indication. It never has. The confusion is understandable — Trulicity belongs to the same GLP-1 receptor agonist drug class as Ozempic and Wegovy, and the

Dulaglutide (Trulicity) Explained: A Weekly GLP-1 With a Cardiovascular Outcomes Story Read More »

Scroll to Top